Stockscreener 앱 받기
1.69
0.00%
0.00
시간 외 거래:
1.73
0.04
+2.37%
전일 마감가:
$1.69
열려 있는:
$1.71
하루 거래량:
47,232
Relative Volume:
0.18
시가총액:
$72.60M
수익:
$51.13M
순이익/손실:
$-93.80M
주가수익비율:
-0.7578
EPS:
-2.23
순현금흐름:
$-129.10M
1주 성능:
+1.20%
1개월 성능:
+9.74%
6개월 성능:
+39.67%
1년 성능:
-38.55%
1일 변동 폭
$1.67
$1.71
1주일 범위
$1.5802
$1.73
52주 변동 폭
$0.89
$4.0695
Repare Therapeutics Inc Stock (RPTX) Company Profile
명칭
Repare Therapeutics Inc
전화
(857) 412-7018
주소
7171 FREDERICK BANTING, SAINT-LAURENT, QC
RPTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RPTX
Repare Therapeutics Inc
|
1.69 | 72.60M | 51.13M | -93.80M | -129.10M | -2.23 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-06-09 | 업그레이드 | Stifel | Hold → Buy |
| 2023-02-03 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-06 | 개시 | CapitalOne | Overweight |
| 2022-04-12 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-03-17 | 재개 | Goldman | Buy |
| 2021-09-23 | 개시 | Stifel | Buy |
| 2021-09-13 | 개시 | H.C. Wainwright | Buy |
| 2021-06-28 | 개시 | Guggenheim | Buy |
| 2021-03-01 | 개시 | Berenberg | Buy |
| 2020-10-28 | 개시 | Northland Capital | Outperform |
| 2020-07-14 | 개시 | Cowen | Outperform |
| 2020-07-14 | 개시 | Goldman | Neutral |
| 2020-07-14 | 개시 | Morgan Stanley | Overweight |
| 2020-07-14 | 개시 | Piper Sandler | Overweight |
모두보기
Repare Therapeutics Inc 주식(RPTX)의 최신 뉴스
Repare Therapeutics Inc. $RPTX is MPM Asset Management LLC's 5th Largest Position - MarketBeat
What data driven models say about Repare Therapeutics Inc.’s future2025 Support & Resistance & Consistent Profit Alerts - Newser
Evaluating Repare Therapeutics Inc. with trendline analysisMarket Performance Summary & Capital Protection Trade Alerts - Newser
Published on: 2025-09-06 20:09:02 - Newser
Ranking Repare Therapeutics Inc. among high performing stocks via tools2025 Retail Activity & Real-Time Volume Triggers - Newser
Is Repare Therapeutics Inc. forming a breakout patternJuly 2025 Analyst Calls & Verified Technical Trade Signals - خودرو بانک
Will Repare Therapeutics Inc. benefit from green energy policiesJuly 2025 Patterns & Long-Term Capital Growth Strategies - خودرو بانک
How to read the order book for Repare Therapeutics Inc.2025 Year in Review & Real-Time Stock Price Movement Reports - Newser
Can volume confirm reversal in Repare Therapeutics Inc.July 2025 Closing Moves & Weekly Market Pulse Alerts - Newser
Key resistance and support levels for Repare Therapeutics Inc.Wall Street Watch & Risk Managed Investment Signals - Newser
Will earnings trigger a reversal in Repare Therapeutics Inc.2025 Investor Takeaways & Technical Buy Zone Confirmation - Newser
Using R and stats models for Repare Therapeutics Inc. forecastingWeekly Trend Recap & High Conviction Buy Zone Alerts - Newser
Is it time to cut losses on Repare Therapeutics Inc.2025 Risk Factors & Long-Term Growth Portfolio Plans - Newser
What’s the recovery path for long term holders of Repare Therapeutics Inc.July 2025 WrapUp & Free Long-Term Investment Growth Plans - Newser
Market reaction to Repare Therapeutics Inc.’s recent newsJuly 2025 PostEarnings & Short-Term Swing Trade Alerts - Newser
Repare Therapeutics Inc. stock prediction for this weekWeekly Profit Summary & Long Hold Capital Preservation Tips - Newser
Chart based analysis of Repare Therapeutics Inc. trendsJuly 2025 Market Mood & Fast Exit Strategy with Risk Control - Newser
Can Repare Therapeutics Inc. be recession proofM&A Rumor & Risk Adjusted Buy and Sell Alerts - خودرو بانک
MPM Bioimpact LLC Trims Position in Repare Therapeutics Inc. $RPTX - MarketBeat
Is Repare Therapeutics Inc. meeting your algorithmic filter criteriaWeekly Profit Report & AI Forecast Swing Trade Picks - Newser
What does recent volatility data suggest for Repare Therapeutics Inc.2025 Technical Patterns & High Accuracy Swing Entry Alerts - Newser
How to track smart money flows in Repare Therapeutics Inc.2025 Risk Factors & Smart Money Movement Alerts - Newser
Quantitative breakdown of Repare Therapeutics Inc. recent moveMarket Rally & Free Safe Capital Growth Stock Tips - Newser
Backtesting results for Repare Therapeutics Inc. trading strategiesMarket Risk Analysis & Weekly High Potential Alerts - Newser
Leading vs lagging indicators on Repare Therapeutics Inc. performancePortfolio Gains Summary & Daily Chart Pattern Signals - Newser
Is Repare Therapeutics Inc. benefiting from innovation trendsJuly 2025 Volume & Weekly High Return Stock Forecasts - خودرو بانک
Earnings Update: Will Repare Therapeutics Inc. benefit from green energy policiesMarket Risk Report & Community Supported Trade Ideas - خودرو بانک
What momentum shifts mean for Repare Therapeutics Inc.Trend Reversal & AI Enhanced Execution Alerts - Newser
Is Repare Therapeutics Inc. stock a good dividend stock2025 Price Targets & Daily Entry Point Alerts - خودرو بانک
Should you wait for a breakout in Repare Therapeutics Inc.Market Risk Report & Reliable Trade Execution Plans - Newser
Is Repare Therapeutics Inc. a potential multi bagger2025 Performance Recap & Low Drawdown Momentum Trade Ideas - خودرو بانک
Does anyone know about the stock REPARE THERAPUTICS and PENN? - AInvest
What’s Repare Therapeutics Inc.’s historical returnJuly 2025 Market Mood & Risk Managed Investment Signals - خودرو بانک
How to recover losses in Repare Therapeutics Inc. stockEarnings Beat & Accurate Entry and Exit Point Alerts - Newser
Repare Therapeutics Inc. Reaches Critical Trendline Support getLinesFromResByArray error: size == 0 - kangso.co.kr
Live market analysis of Repare Therapeutics Inc.Portfolio Return Report & Consistent Income Trade Ideas - Newser
Repare Therapeutics Inc (RPTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):